CD4 and cancer: CD4+IL-17+ T cell subset had a similar tend as that of CD4+IFN-γ+ subset in the absolute cell numbers following the tumor development (Supplemental Figure 2C), but its percentage and relative cell numbers maintained relative higher levels in the late cancer stage compared with IFN-γ+CD4+T cells (Figure 2A–2D).